AnalystsBrian Cheng
Brian Cheng's Stock Forecasts

Analyst Ranking
Top 22%
#1218 out of 5563 analysts
Average Return
+4.83%
Win Rate
43%43 out of 100
Risk vs Reward
Poor
Good

Brian Cheng's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Absci CorpABSI
+202.82%$3.55$10.75
2025-10-02 -
2026-10-01
Strong Buy
Revolution Medicines IncRVMD
+189.43%$61.38$177.65
2025-11-06 -
2026-11-05
Strong Buy
Protagonist Therapeutics IncPTGX
+170.97%$17.19$46.58
2023-09-25 -
2024-09-24
Strong Buy
Immunovant IncIMVT
+169.10%$15.21$40.93
2025-08-12 -
2026-08-11
Strong Buy
Roivant Sciences LtdROIV
+164.94%$15.09$39.98
2025-09-18 -
2026-09-17
Strong Buy

Brian Cheng's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cg Oncology IncCGON
5Strong Buy$113.00+41.25%Maintains
2 days ago
Tango Therapeutics IncTNGX
2Strong Buy$47.00+114.71%Maintains
9 days ago
Trex Bio IncTRXB
1Strong Buy$20.00+112.99%Initiates Coverage On
16 days ago
Absci CorpABSI
2Strong Buy$15.00+83.37%Maintains
a month ago
Ascentage Pharma Group InternationalAAPG
2Strong Buy$33.00+153.59%Maintains
a month ago
Abcellera Biologics IncABCL
1Strong Buy$17.00+54.26%Initiates Coverage On
2 months ago
Dianthus Therapeutics IncDNTH
1Strong Buy$135.00+60.75%Initiates Coverage On
2 months ago
Zymeworks IncZYME
4Strong Buy$33.00+26.73%Maintains
3 months ago
Xencor IncXNCR
8Hold$21.00-38.94%Maintains
3 months ago
Blossomhill Therapeutics IncBLSM
1Strong Buy$28.00+91.91%Initiates Coverage On
3 months ago
Monte Rosa Therapeutics IncGLUE
2Strong Buy$27.00+197.68%Maintains
3 months ago
Tg Therapeutics IncTGTX
2Strong Buy$72.00+8.89%Maintains
3 months ago
Odyssey Therapeutics IncODTX
2Strong Buy$29.00+52.79%Maintains
3 months ago
Immunovant IncIMVT
5Strong Buy$50.00+50.74%Maintains
3 months ago
Shattuck Labs IncSTTK
1Strong Buy$10.00+123.71%Initiates Coverage On
4 months ago
Arrowhead Pharmaceuticals IncARWR
2Strong Buy$95.00+120.37%Maintains
4 months ago
Protara Therapeutics IncTARA
2Strong Buy$26.00+1,011.11%Maintains
6 months ago
Kyverna Therapeutics IncKYTX
3Strong Buy$29.00+547.32%Maintains
6 months ago
Allogene Therapeutics IncALLO
6HoldN/AN/AUpgrades
7 months ago
Protagonist Therapeutics IncPTGX
7Strong Buy$106.00-16.64%Maintains
8 months ago
Eikon Therapeutics IncEIKN
1Strong Buy$29.00+460.93%Initiates Coverage On
9 months ago
Revolution Medicines IncRVMD
2Strong Buy$122.00-23.66%Maintains
10 months ago
Kymera Therapeutics IncKYMR
1Strong Buy$125.00+3.19%Maintains
a year ago
Opko Health IncOPK
1HoldN/AN/AInitiates Coverage On
a year ago
Intellia Therapeutics IncNTLA
5Strong Sell$5.00N/ADowngrades
a year ago
Pliant Therapeutics IncPLRX
1Strong SellN/AN/ADowngrades
a year ago
Roivant Sciences LtdROIV
7Strong Buy$20.00N/AMaintains
a year ago
Crispr Therapeutics AgCRSP
1Strong Buy$70.00N/AInitiates Coverage On
a year ago
Precigen IncPGEN
3HoldN/AN/AUpgrades
a year ago
Immunome IncIMNM
3Strong Buy$22.00N/AMaintains
a year ago
Blueprint Medicines CorpBPMC
3Hold$129.00N/ADowngrades
a year ago
Iteos Therapeutics IncITOS
4Hold$8.00N/ADowngrades
2 years ago
Cargo Therapeutics IncCRGX
2Strong SellN/AN/ADowngrades
2 years ago
Editas Medicine IncEDIT
3Strong SellN/AN/ADowngrades
2 years ago
Metagenomi Therapeutics IncMGX
2Hold$6.00N/ADowngrades
3 years ago
Mersana Therapeutics IncMRSN
3Hold$125.00N/AUpgrades
3 years ago
Bioatla IncBCAB
3Strong Buy$700.00N/AMaintains
3 years ago
Adc Therapeutics SaADCT
3HoldN/AN/AUpgrades
3 years ago
Adicet Bio IncACET
2Hold$96.00N/ADowngrades
3 years ago
Senti Biosciences Holdings IncSNTI
1HoldN/AN/AInitiates Coverage On
4 years ago
Gossamer Bio IncGOSS
2Strong SellN/AN/ADowngrades
4 years ago
Clovis Oncology IncCLVSQ
1Strong SellN/AN/ADowngrades
4 years ago
Poseida Therapeutics IncPSTX
1Strong Buy$24.00N/AInitiates Coverage On
5 years ago
Sierra Oncology IncSRRA
2Strong Buy$39.00N/AMaintains
5 years ago
Regulus Therapeutics IncRGLS
2Strong Buy$20.00N/AInitiates Coverage On
5 years ago
Arcturus Therapeutics Holdings IncARCT
2Strong Buy$85.00N/AMaintains
5 years ago
Biocryst Pharmaceuticals IncBCRX
1Strong Buy$21.00N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.